Acamoli

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acamoli

Defining Acamoli: The Identity and Pharmacological Class

Acamoli is a preparation containing the synthetic active ingredient Paracetamol, which is internationally recognized as Acetaminophen. This substance is classified as a non-opioid analgesic and an antipyretic agent. Acetaminophen is primarily used to provide symptomatic relief from pain and fever. Unlike certain multi-symptom analgesic preparations, Acamoli is typically marketed as a single-ingredient product, intended for focused action without additional compounds such as caffeine or decongestants.

Forms, Composition, and General Benefit

The active compound, N-(4-hydroxyphenyl)acetamide, is available in several dosage forms, including oral tablets, liquid oral suspensions, and suppositories. These options allow for various routes of administration tailored to different patient groups, including children. This versatility in form supports the use of both rectal and oral formulations depending on the clinical need. Paracetamol is one of the most widely used agents for treating pain and fever, providing a standard option for managing common headaches or temporary fever.

Mechanism Insight: How it Works to Relieve Symptoms

The medication acts primarily on the central nervous system, rather than exhibiting the intense peripheral activity characteristic of non-steroidal anti-inflammatory drugs (NSAIDs). Its mechanism involves interfering with the synthesis of prostaglandins—the chemical signals that mediate pain and temperature regulation. This central action allows the body’s thermoregulatory center in the hypothalamus to effectively reset its temperature, facilitating fever reduction and decreasing the overall perception of pain.

Regulatory References

  1. Acetaminophen: MedlinePlus Drug Information
  2. Acetaminophen - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Acamoli?

Possible side effects and safety information

Acamoli, containing Acetaminophen (Paracetamol), is associated with a low incidence of adverse reactions when used appropriately. The safety profile, as documented by official regulatory authorities, is structured around the potential for hepatotoxicity (liver damage) and the risk of severe hypersensitivity reactions.

Serious Adverse Reactions and Systemic Effects

The primary safety constraint is the potential for severe liver damage, which is explicitly noted as a risk of excessive use or overdose, potentially leading to acute liver failure. The official labeling recognizes the possibility of rare but serious events classified across several system-organ classes:

  • Skin and Subcutaneous Tissue Disorders: Very rare cases of severe, life-threatening skin reactions are documented, including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP).
  • Immune System Disorders: Rare allergic reactions and, less frequently, severe reactions such as anaphylactic shock and angioedema may occur.
  • Blood and Lymphatic System Disorders: Rare forms of blood dyscrasias are reported, including thrombocytopenia and agranulocytosis.

Population-Specific and Duration-Related Safety Notes

The hazard of liver damage is documented to be greater in individuals with non-cirrhotic alcoholic liver disease and those with severe hepatic impairment. Caution is also advised for administration to patients with severe renal impairment.

Furthermore, the official safety notes indicate that the anticoagulant effect of certain medications may be enhanced by prolonged regular daily use of Acamoli. The regulatory framework emphasizes that co-administration with any other product containing Acetaminophen (Paracetamol) is a safety restriction due to the compounded risk of liver toxicity.

Overdose and Emergency Response

Overdose: When to Seek Immediate Medical Help

Acamoli, when taken in excessive amounts, can cause serious and potentially fatal liver damage. An overdose is a medical emergency, and the damage to the liver often progresses without obvious symptoms in the early stages.

Immediately seek emergency medical attention if you suspect that you or someone else has taken too much Acamoli, even if you feel completely fine. Do not wait for symptoms to appear.

Early Overdose Symptoms (May Be Delayed)
Nausea, vomiting, and stomach pain
Loss of appetite or general weakness
Often, there are no symptoms initially

Delayed and Severe Symptoms

Symptoms of severe liver damage may not appear until 24 to 48 hours or more after the ingestion. These serious signs include:

  • Jaundice (yellowing of the skin or eyes)
  • Severe abdominal pain or tenderness
  • Confusion or extreme drowsiness

Risk Factors

The risk of liver injury is higher for certain individuals, including those with chronic alcohol use, malnutrition, low body weight, or those taking other medicines that affect the liver. If the overdose involves an extended-release formulation, the toxic effects may be unpredictable.

Timely treatment with the antidote, N-acetylcysteine, is critical; effectiveness is highest when given within eight hours of ingestion. Always provide medical professionals with the exact dose and time the medication was taken.

Therapeutic Uses of Acamoli

What Acamoli Treats: Main Uses and Benefits

Acamoli, containing Acetaminophen (Paracetamol), is commonly used for symptomatic relief in clinical situations marked by symptoms related to heightened physiological activity, such as pain and fever. The medication is used to relieve mild to moderate pain and to reduce fever, and is applied across domains where additional symptomatic support is needed to ease the overall burden of symptoms.

The analgesic action is relevant for easing discomfort from symptoms related to physical discomfort, and is commonly used to help with manifestations such as tension headaches, mild migraines, musculoskeletal aches, dental pain, and dysmenorrhea. The antipyretic function plays a role in managing symptoms related to systemic imbalance, such as the malaise and fever linked to viral syndromes and post-immunization responses.

Quick Fact: Relief for Acute Discomfort

Acamoli is commonly used across conditions presenting with acute episodes where symptoms may intensify temporarily, providing supportive relief that contributes to improved comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Acamoli — Official Regulatory Information

Acamoli, containing Acetaminophen (Paracetamol), is governed by regulatory documents that define specific patient groups who are permitted, restricted, or prohibited from using the medicine.

Eligibility scope Classification
Populations for whom use is allowed Adults and adolescents (ge 12 years); Children ge 2 years; Pregnant and breastfeeding patients (when clinically needed and used correctly).
Populations for whom use is contraindicated Patients with known hypersensitivity or allergy to Acetaminophen; Patients with severe hepatic impairment or severe active liver disease.
Populations requiring caution/restriction Patients with severe renal impairment (CreCL le 30 mL/min); Patients with chronic alcoholism or chronic malnutrition; Patients who are dehydrated or have non-severe active hepatic disease.

Age-Related and Condition-Specific Eligibility

  • Pediatric patients: Use is generally established for children 2 years of age and older. Use in children younger than 2 years of age is not established for certain formulations, and over-the-counter use is generally not recommended without medical guidance.
  • Organ Function: Severe hepatic impairment is an absolute contraindication. Patients with severe renal impairment require caution, and a longer interval between doses may be warranted as stated in the label.
  • Physiological Status: Regulatory bodies recommend Acamoli as the first-choice analgesic/antipyretic for use in both pregnancy and lactation, provided it is taken at the lowest effective dose for the shortest duration necessary.

These classifications strictly define eligibility, focusing on underlying conditions that impact the drug’s metabolism.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Acamoli, which contains Acetaminophen (Paracetamol), is defined by pharmacokinetic and pharmacodynamic patterns documented in official regulatory labeling.

Pharmacokinetic and Metabolic Interactions

Co-administration with Probenecid reduces Acamoli clearance, resulting in an increase in the drug's plasma concentrations. Conversely, oral contraceptives may increase Acamoli clearance. Co-ingestion of Colestyramine reduces the rate of absorption and requires a mandatory administration separation; Colestyramine must not be taken within one hour of Acamoli. Interactions that increase the potential for toxicity occur with agents like Phenobarbital or chronic alcohol use, as these substances may enhance the metabolic formation of the drug's reactive metabolite.

Pharmacodynamic Interactions

The most significant pharmacodynamic interaction is with Warfarin and other coumarin derivatives. Co-administration, particularly at high doses or for prolonged periods, is officially documented to potentiate the anticoagulant effect, thereby increasing the risk of bleeding. The co-administration with Zidovudine is also documented to reduce the clearance of Zidovudine, which may lead to increased Zidovudine plasma exposure.

Population and Substance Constraints

Regulatory documents highlight that the risk and severity of interaction-mediated outcomes are heightened in populations with hepatic impairment and in individuals with a history of chronic alcohol use.

Mechanism of Action

The pharmacodynamic action of Acamoli (acetaminophen/paracetamol) is mediated primarily within the central nervous system (CNS) through two distinct mechanistic domains: enzyme modulation and neurotransmitter pathway engagement.

Modulation of Central Prostaglandin Synthesis

Acamoli functions as a presumed inhibitor of the cyclooxygenase (COX) enzymes, particularly within the CNS. This interaction modifies early molecular steps, resulting in the diminished synthesis of local prostaglandins, such as PGE2. This pathway effect contributes to influencing hypothalamic thermoregulation and the processing of nociceptive signals within the spinal cord and brain.

Central Pathway Regulation and Receptor Engagement

Beyond COX inhibition, Acamoli and its active metabolite, AM404, engage multiple central signaling mechanisms. This includes the modulation of the serotonergic descending inhibitory pathway. Furthermore, AM404 interacts with the transient receptor potential vanilloid-1 (TRPV1) receptors and influences the endocannabinoid system. This engagement of diverse receptor and pathway systems within the CNS modulates the activity of pathways involved in heightened physiological responses.

Dosage and Administration Information

The usage of Acamoli (Acetaminophen/Paracetamol) is defined by standardized administration protocols. The medicine is available for administration via the Oral, Rectal, and Intravenous (IV) routes.

Administration Dosing and Frequency

Entity Official Guideline
Standard Adult Dose 500 mg to 1000 mg per dose. The maximum total daily dose from all combined routes must not exceed 4000 mg (4 g).
Dosing Frequency Doses are administered every 4 to 6 hours as needed, maintaining a minimum interval of 4 hours between successive doses.
Special Procedures Oral suspension requires precise measurement with the provided dosing device. The IV formulation must be given as a controlled infusion over 15 minutes.

Population-Specific Use

Dosing regimens require modification in specific populations. For pediatric patients, the dose is calculated based on body weight (10–15 mg/kg per dose). In patients with severe hepatic impairment or significant renal impairment, protocols require the dose to be reduced or the dosing interval to be prolonged, often to 6 to 8 hours. The medicine is intended for short-term use, with IV administration often limited to a maximum of five days in the hospital setting. The overall administration protocol involves monitoring the total daily amount consumed across all forms to remain within the established limit.

Recent Clinical Evidence

Acamoli: Recent Clinical Evidence

Evidence for Short-Term Relief of Fever and Acute Pain

Research has extensively focused on studies exploring outcomes related to physical discomfort (pain) and systemic or functional imbalance (fever) following the administration of Acamoli. The evidence base, primarily Randomized Controlled Trials (RCTs), examined short-term changes in these acute conditions. Research describes data show patterns related to participants' pain scores and changes measured in body temperature over short, defined time intervals. However, long-term effects are not fully established for the repeated, sustained use, and the follow-up durations were limited in many trials.

Role in Post-operative Pain Management

Acamoli was studied for its potential role as part of a multimodal analgesic approach for patients recovering from surgery. Studies reported patterns where the use of Acamoli as part of a combined regimen was associated with measurements of decreased opioid utilization during the early post-operative period. Research provides insight into short-term changes. What remains uncertain is the optimal timing and specific dosage across the entire spectrum of surgical procedures; data are still emerging.

Research in Chronic Conditions and Study Limitations

Acamoli was evaluated in research exploring its potential role in conditions such as osteoarthritis (OA). Early research reported patterns observed in the studies related to pain intensity measurements. However, more recent, comprehensive meta-analyses reported findings that were mixed regarding the magnitude of the observed effects on outcomes reflecting daily functioning. The quality of evidence varies across studies, meaning certainty remains low regarding the consistency of findings for many individuals with long-standing OA.

Across all indications, the follow-up durations were limited. Research has examined its use in pediatric populations and older adults; however, specific trials for patients with certain comorbid conditions are limited, and few data are available for pregnancy-related populations. Ultimately, results apply only to the populations studied, and research provides context but not individual predictions regarding extended use.

Key Studies & References

  1. IV Acetaminophen for Acute Pain in Emergency Departments (Summary of RCTs and SRs) – NCBI Bookshelf
  2. Acetaminophen for Chronic Pain: A Systematic Review on Efficacy (Focus on Osteoarthritis and limited evidence)
  3. Opioid-Sparing Effects of IV Acetaminophen for Patients Undergoing Surgery – NCBI Bookshelf (Systematic Review)

Frequently Asked Questions (FAQ)

Common questions about Acamoli (FAQ)


Q: What is the main difference between Acamoli and Tylenol?

A: Tylenol is a specific brand name for products containing the active ingredient acetaminophen. Acamoli is a common preparation or reference to the same active ingredient, Acetaminophen (Paracetamol). Therefore, they contain the same primary medicinal component.


Q: Is Acamoli an NSAID like ibuprofen?

A: No, Acamoli is not an NSAID (non-steroidal anti-inflammatory drug) like ibuprofen or naproxen. It is classified as a non-opioid analgesic and antipyretic. Its mechanism of action to relieve pain and fever is distinct from that of NSAIDs.


Q: How quickly should I expect Acamoli to start working for pain?

A: Following an oral dose, the pain-relieving effects of Acamoli typically begin within 30 minutes. The drug usually reaches its highest concentration in the blood within 30 minutes to 2 hours, coinciding with maximum effect.


Q: How long does the effect of one dose of Acamoli usually last?

A: The therapeutic effect of a single dose of Acamoli is generally expected to last for approximately 4 to 6 hours. This duration aligns with the standard recommended dosing interval.


Q: Can Acamoli cause stomach upset or nausea?

A: While the primary serious risk is liver damage, regulatory adverse event reports do list side effects like nausea, vomiting, and abdominal pain as possible occurrences. These are not classified as common for single-ingredient acetaminophen but can occur.


Q: Does Acamoli interact with common cold or flu medications?

A: Official labels carry a critical warning that one should not combine Acamoli with any other product that contains acetaminophen (Paracetamol). Many common cold, flu, and sinus medications contain this ingredient, and combining them can lead to accidental overdose and severe liver damage.


Q: Can older adults or seniors take Acamoli safely?

A: Acamoli is generally safe for older adults. However, clinical guidance suggests that dose adjustments or prolonged dosing intervals may be required in the elderly population due to potential age-related changes in how the body processes the medication, particularly if kidney function is reduced.


Q: Will Acamoli make me feel drowsy or sleepy?

A: Drowsiness or feeling sleepy is not a common side effect of single-ingredient Acamoli (Acetaminophen). Official product information often lists drowsiness, or somnolence, among the less frequent reactions for some acetaminophen-containing products, but it is not typically associated with this medication alone.


Q: Can I drink coffee while taking Acamoli?

A: Regulatory documents covering the use of Acamoli do not list coffee or caffeine as a specific substance that must be avoided. Regulatory warnings primarily focus on the risk associated with chronic alcohol use and interactions with specific prescription medications.


Q: Is it normal to feel a bit dizzy after taking Acamoli?

A: While it is not considered a common reaction, regulatory adverse event reports for acetaminophen products list dizziness as a possible, but infrequent, side effect. Patients experiencing unexpected or severe dizziness may wish to consult a healthcare professional.


Q: Is there a maximum number of days I can take Acamoli in a row?

A: Official guidelines recommend using Acamoli for the shortest duration necessary to treat your symptoms. For over-the-counter use, package directions typically recommend limiting administration to a short, specified duration. It is important to follow the time limits provided on the specific product label.


Q: Does taking Acamoli affect my blood pressure?

A: Regulatory documents list both changes in blood pressure, including low blood pressure (hypotension) and high blood pressure (hypertension), among the reported cardiovascular effects. However, these are generally classified as infrequent or rare events associated with the use of acetaminophen.


Q: What should I avoid eating or drinking while using Acamoli?

A: The primary substance constraint highlighted in official warnings is chronic or excessive alcohol consumption due to the significantly increased risk of liver damage. No specific general food items are typically listed as substances to be avoided while using this medication.


Q: Are there any known herbal supplements that interact with Acamoli?

A: While official prescribing information focuses on interactions with prescription drugs, regulatory-adjacent sources advise caution with some herbal supplements that are known to impact liver function. Patients are advised to be cautious with any supplements that could affect liver function, as this may add to the potential risk associated with Acamoli's metabolism.


Q: Are allergic reactions to Acamoli common?

A: Severe, life-threatening allergic reactions, such as anaphylactic shock and severe skin conditions (e.g., Stevens-Johnson Syndrome), are classified as rare events in regulatory documents. Patients experiencing signs of an allergic reaction are directed by regulatory labels to discontinue use and seek immediate medical assistance.


Q: Does Acamoli work for menstrual pain?

A: Yes, Acamoli (Acetaminophen) is indicated for the symptomatic relief of various forms of mild to moderate pain, which includes menstrual pain. It works by targeting the pain signals in the central nervous system.


Q: Is it okay to take Acamoli if I have asthma?

A: Official guidelines do not generally list asthma as a reason to avoid taking the medication. However, some adverse reaction reports mention that bronchospasm or asthma-like symptoms can occur among the rare hypersensitivity reactions in susceptible individuals.


Q: How long does Acamoli stay in your system after the last dose?

A: The body eliminates Acamoli primarily through metabolism in the liver. The elimination half-life is typically short, meaning the concentration in the blood is reduced by half within a few hours. Complete elimination is expected within one day, though this can vary based on individual factors.


Q: Is Acamoli effective for toothaches?

A: Yes, as an analgesic, Acamoli is indicated for general pain relief. Clinical reviews confirm it is commonly and effectively used by patients to manage acute dental pain, such as toothaches.


Q: Why do some people say Acamoli is 'gentler on the stomach'?

A: This belief is based on Acamoli's mechanism of action, which primarily works on the central nervous system. It differs from NSAIDs, which can cause irritation by inhibiting prostaglandins in the stomach lining. Acamoli has less potential for gastrointestinal side effects compared to NSAIDs.


Q: Does Acamoli have any known interactions with alcohol?

A: Yes. Regulatory warnings state that the risk of severe liver damage is significantly increased in individuals who are chronic heavy drinkers while using acetaminophen.


Q: What are the signs of taking too much Acamoli?

A: The serious risk of overdose is severe liver damage. Initial signs may be subtle and include non-specific flu-like symptoms, such as nausea, vomiting, loss of appetite, and abdominal pain. If an overdose is suspected, it is necessary to seek immediate medical attention.


Q: Does Acamoli help reduce inflammation?

A: Acamoli is primarily indicated as an analgesic (pain reliever) and antipyretic (fever reducer). It is not typically classified as an anti-inflammatory drug, as its ability to reduce inflammation is not considered clinically significant when compared to drugs like NSAIDs.


Q: What is the difference between immediate-release and extended-release Acamoli?

A: The Immediate-Release (IR) formulations quickly release the medication for fast relief, lasting about 4–6 hours. Extended-Release (ER) formulations are designed to release the medication slowly over a longer period to provide sustained relief.


Q: Can I take Acamoli if I have a history of ulcers?

A: Regulatory guidance highlights that Acamoli works differently from NSAIDs, which are often restricted in patients with a history of ulcers. Since Acamoli's mechanism of action has less impact on the stomach lining, it is often an alternative pain relief option for individuals who need to avoid NSAIDs.

How should Acamoli be stored and disposed of?

Acamoli, containing acetaminophen, must be stored under specific environmental and container conditions as directed by regulatory labeling to maintain its quality.

Official Storage and Disposal Statements

  • The product must be stored at room temperature, generally between 20 C to 25 C (68 F to 77 F), and must be kept from freezing.
  • It requires protection from excess heat, light, and moisture to prevent degradation.
  • The medicine must remain in its original container, which should be kept tightly closed.
  • A mandatory safety rule is to keep the medicine out of the sight and reach of children.
  • Disposal of unused or expired product should occur through a designated drug take-back program or by following the official household disposal steps (mixing with an undesirable substance and sealing it).
  • The product should not be flushed down the toilet or poured down the sink unless specifically authorized by official labeling.

These instructions outline the precise regulatory requirements for handling and discarding the medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acamoli found in:

A-Z Index: